Neogen Corporation Investment Income, Interest
Neogen Corporation (NEOG) reported Investment Income, Interest of $524.00 thousand for the 3-month period ending 2018-02-28, per its 10-Q filed 2018-03-29.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeInterest · last filed 2018-03-29
- Neogen Corporation investment income, interest for the quarter ending 2018-02-28 was $524.00K, a 93.36% increase year-over-year.
- Neogen Corporation investment income, interest for the quarter ending 2017-11-30 was $429.00K, a 44.93% increase year-over-year.
- Neogen Corporation investment income, interest for the quarter ending 2017-08-31 was $369.00K, a 200.00% increase year-over-year.
- Neogen Corporation investment income, interest for the quarter ending 2017-05-31 was $148.00K, a 76.19% increase year-over-year.
- Neogen Corporation investment income, interest for fiscal 2017 was $838.00K, a 160.25% increase from fiscal 2016.
- Neogen Corporation investment income, interest for fiscal 2016 was $322.00K, a 41.23% increase from fiscal 2015.
- Neogen Corporation investment income, interest for fiscal 2015 was $228.00K, a 98.26% increase from fiscal 2014.
- Neogen Corporation investment income, interest for fiscal 2014 was $115.00K, a 20.14% decline from fiscal 2013.
| Period end | Investment Income, Interest 3 month | Investment Income, Interest 6 month | Investment Income, Interest 9 month | Investment Income, Interest 12 month |
|---|---|---|---|---|
| 2018-02-28 | $524.00K 10-Q · filed 2018-03-29 | $953.00K derived: sum of 2 quarters · filed 2018-03-29 | $1.32M 10-Q · filed 2018-03-29 | $1.47M derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-11-30 | $429.00K 10-Q · filed 2018-01-05 | $798.00K 10-Q · filed 2018-01-05 | $946.00K derived: sum of 3 quarters · filed 2018-01-05 | $1.22M derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-08-31 | $369.00K 10-Q · filed 2017-09-29 | $517.00K derived: sum of 2 quarters · filed 2017-09-29 | $788.00K derived: sum of 3 quarters · filed 2018-03-29 | $1.08M derived: sum of 4 quarters · filed 2018-03-29 |
| 2017-05-31 | $148.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $419.00K derived: sum of 2 quarters · filed 2018-03-29 | $715.00K derived: sum of 3 quarters · filed 2018-03-29 | $838.00K 10-K · filed 2017-07-28 |
| 2017-02-28 | $271.00K 10-Q · filed 2018-03-29 | $567.00K derived: sum of 2 quarters · filed 2018-03-29 | $690.00K 10-Q · filed 2018-03-29 | $774.00K derived: sum of 4 quarters · filed 2018-03-29 |
| 2016-11-30 | $296.00K 10-Q · filed 2018-01-05 | $419.00K 10-Q · filed 2018-01-05 | $503.00K derived: sum of 3 quarters · filed 2018-01-05 | $623.00K derived: sum of 4 quarters · filed 2018-01-05 |
| 2016-08-31 | $123.00K 10-Q · filed 2017-09-29 | $207.00K derived: sum of 2 quarters · filed 2017-09-29 | $327.00K derived: sum of 3 quarters · filed 2017-09-29 | $378.00K derived: sum of 4 quarters · filed 2017-09-29 |
| 2016-05-31 | $84.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $204.00K derived: sum of 2 quarters · filed 2017-07-28 | $255.00K derived: sum of 3 quarters · filed 2017-07-28 | $322.00K 10-K · filed 2017-07-28 |
| 2016-02-29 | $120.00K 10-Q · filed 2017-03-31 | $171.00K derived: sum of 2 quarters · filed 2017-03-31 | $238.00K 10-Q · filed 2017-03-31 | $309.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-11-30 | $51.00K 10-Q · filed 2016-12-29 | $119.00K 10-Q · filed 2016-12-29 | $189.00K derived: sum of 3 quarters · filed 2017-07-28 | $255.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-08-31 | $68.00K 10-Q · filed 2016-09-30 | $138.00K derived: sum of 2 quarters · filed 2017-07-28 | $204.00K derived: sum of 3 quarters · filed 2017-07-28 | $251.00K derived: sum of 4 quarters · filed 2017-07-28 |
| 2015-05-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-07-28 | $136.00K derived: sum of 2 quarters · filed 2017-07-28 | $183.00K derived: sum of 3 quarters · filed 2017-07-28 | $228.00K 10-K · filed 2017-07-28 |
| 2015-02-28 | $66.00K 10-Q · filed 2016-03-31 | $113.00K derived: sum of 2 quarters · filed 2016-03-31 | $158.00K 10-Q · filed 2016-03-31 | $185.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-11-30 | $47.00K 10-Q · filed 2016-01-08 | $92.00K 10-Q · filed 2016-01-08 | $119.00K derived: sum of 3 quarters · filed 2016-07-29 | $147.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-08-31 | $45.00K 10-Q · filed 2015-09-30 | $72.00K derived: sum of 2 quarters · filed 2016-07-29 | $100.00K derived: sum of 3 quarters · filed 2016-07-29 | $128.00K derived: sum of 4 quarters · filed 2016-07-29 |
| 2014-05-31 | $27.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-07-29 | $55.00K derived: sum of 2 quarters · filed 2016-07-29 | $83.00K derived: sum of 3 quarters · filed 2016-07-29 | $115.00K 10-K · filed 2016-07-29 |
| 2014-02-28 | $28.00K 10-Q · filed 2015-04-01 | $56.00K derived: sum of 2 quarters · filed 2015-04-01 | $88.00K 10-Q · filed 2015-04-01 | $117.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-11-30 | $28.00K 10-Q · filed 2014-12-30 | $59.00K 10-Q · filed 2014-12-30 | $89.00K derived: sum of 3 quarters · filed 2015-07-30 | $122.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-08-31 | $31.00K 10-Q · filed 2014-09-30 | $61.00K derived: sum of 2 quarters · filed 2015-07-30 | $94.00K derived: sum of 3 quarters · filed 2015-07-30 | $137.00K derived: sum of 4 quarters · filed 2015-07-30 |
| 2013-05-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-30 | $63.00K derived: sum of 2 quarters · filed 2015-07-30 | $106.00K derived: sum of 3 quarters · filed 2015-07-30 | $144.00K 10-K · filed 2015-07-30 |
| 2013-02-28 | $33.00K 10-Q · filed 2014-04-04 | $76.00K derived: sum of 2 quarters · filed 2014-04-04 | $114.00K 10-Q · filed 2014-04-04 | $143.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-11-30 | $43.00K 10-Q · filed 2014-01-09 | $81.00K 10-Q · filed 2014-01-09 | $110.00K derived: sum of 3 quarters · filed 2014-07-30 | $140.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-08-31 | $38.00K 10-Q · filed 2013-09-30 | $67.00K derived: sum of 2 quarters · filed 2014-07-30 | $97.00K derived: sum of 3 quarters · filed 2014-07-30 | $123.00K derived: sum of 4 quarters · filed 2014-07-30 |
| 2012-05-31 | $29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-07-30 | $59.00K derived: sum of 2 quarters · filed 2014-07-30 | $85.00K derived: sum of 3 quarters · filed 2014-07-30 | $107.00K 10-K · filed 2014-07-30 |
| 2012-02-29 | $30.00K 10-Q · filed 2013-03-28 | $56.00K derived: sum of 2 quarters · filed 2013-03-28 | $78.00K 10-Q · filed 2013-03-28 | $103.00K derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-11-30 | $26.00K 10-Q · filed 2012-12-28 | $48.00K 10-Q · filed 2012-12-28 | $73.00K derived: sum of 3 quarters · filed 2013-07-30 | $86.00K derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-08-31 | $22.00K 10-Q · filed 2012-09-28 | $47.00K derived: sum of 2 quarters · filed 2013-07-30 | $60.00K derived: sum of 3 quarters · filed 2013-07-30 | $88.00K derived: sum of 4 quarters · filed 2013-07-30 |
| 2011-05-31 | $25.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-07-30 | $38.00K derived: sum of 2 quarters · filed 2013-07-30 | $66.00K derived: sum of 3 quarters · filed 2013-07-30 | $95.00K 10-K · filed 2013-07-30 |
| 2011-02-28 | $13.00K 10-Q · filed 2012-03-30 | $41.00K derived: sum of 2 quarters · filed 2012-03-30 | $70.00K 10-Q · filed 2012-03-30 | |
| 2010-11-30 | $28.00K 10-Q · filed 2011-12-30 | $57.00K 10-Q · filed 2011-12-30 | ||
| 2010-08-31 | $29.00K 10-Q · filed 2011-09-30 | |||
| 2010-05-31 | $81.00K 10-K · filed 2012-07-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |